Sakar Healthcare is set to manufacture and supply oncology products for Intas’ fully owned subsidiary ACCORD Healthcare in the EU, UK & Emerging markets. The technology transfer process has been initiated for already registered 7 oncology products (5 oral solids/ 2 injections) at Sakar's research-driven API-integrated EU GMP approved oncology finished dosage formulation manufacturing unit.
Accord ranked amongst top-3 in most EU markets with core supply of anti-cancer products and operates in over 45 countries with major focus and supply of generic oncology products covering hospitals and retail pharmacies across Europe and the rest of the world. This strategic move is certain to increase Sakar's supply of oncology products in the EU, UK markets, in addition to registration of products in own name.
Sakar Healthcare is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: